Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 19  •  04:00PM ET
27.38
Dollar change
+0.33
Percentage change
1.21
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y6.09% Total Holdings70 Perf Week0.22%
SponsorFidelity ETF Type Tagsequity Return% 3Y- AUM60.27M Perf Month3.27%
Fund Family Bond Type Tagstechnology Return% 5Y- NAV/sh Perf Quarter12.74%
Index- Average Maturity Tagsmedical Return% 10Y 52W High27.41 -0.11% Perf Half Y18.27%
Index Weighting Commodity Type Tagsdisruptive Return% SI 52W Low20.69 32.33% Perf YTD11.03%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% Volatility1.49% 1.10% Perf Year10.98%
Dividend TTM0.11 (0.41%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.38 Perf 3Y-
Dividend Ex-DateDec 20, 2024 Dividend Type Sector/Theme Flows% YTD4.08% RSI (14)65.31 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.92 Perf 10Y-
Expense0.50% Growth/Value SMA203.13% Flows% 3Y Rel Volume4.72 Prev Close27.05
Inverse/Leveraged Market Cap SMA506.26% Flows% 5Y Avg Volume4.56K Price27.38
IPOJun 12, 2023 Option/ShortNo / Yes SMA20012.04% Trades Volume21,529 Change1.21%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.